We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Senate Hearing Urges FDA to Improve Compassionate Use Program
Senate Hearing Urges FDA to Improve Compassionate Use Program
The Senate was urged Thursday to permanently reauthorize the Creating Hope Act, which would provide market incentives to pharmaceutical companies to develop drugs for pediatric rare diseases, ahead of a March 9 markup of the bill by the Senate HELP Committee.